Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03738488
What this trial is testing

3D-biomodels for Surgical Planning in Patients With Renal Cancer and Vascular Involvement

Who this might be right for
Renal Cell CarcinomaThree-DimensionalVenous Thromboses
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 10
Testing effectiveness (Phase 2)Ended earlyNCT02626754
What this trial is testing

A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population

Who this might be right for
Renal Cell Carcinoma
vghtpe user 13
Large-scale testing (Phase 3)Looking for participantsNCT05987241
What this trial is testing

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaMuscle Invasive Renal Pelvis Urothelial CarcinomaMuscle Invasive Ureter Urothelial Carcinoma+4 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT05318196
What this trial is testing

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

Who this might be right for
Acute Kidney InjuryChronic Kidney DiseasesSolid-organ Transplantation+3 more
University Hospital, Toulouse 5,000
Not applicableStudy completedNCT03133286
What this trial is testing

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

Who this might be right for
Radiation TherapyCancerCancer of Anus+16 more
DxTerity Diagnostics 16
Not applicableStudy completedNCT00758108
What this trial is testing

Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions

Who this might be right for
WAGR SyndromeWilm's TumorAniridia+2 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 197
Not applicableStudy completedNCT01968447
What this trial is testing

Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex

Who this might be right for
Prostate CancerRenal Cancer
Leiden University Medical Center 40
Not applicableEnded earlyNCT01195649
What this trial is testing

Advanced Renal Cell Carcinoma, With Failure or Unsuitable on Prior Interferon-alpha or Interleukin-2 Based Therapy

Who this might be right for
Carcinoma, Renal Cell
Bayer 11
Large-scale testing (Phase 3)Study completedNCT00003376
What this trial is testing

Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group 330
Testing effectiveness (Phase 2)Looking for participantsNCT07233252
What this trial is testing

Nephron-sparing Treatment of Tislelizumab + Nab-Paclitaxel for Renal Pelvic Cancer

Who this might be right for
Renal Pelvic CarcinomaTislelizumabPD-1 Inhibitor+2 more
Tianjin Medical University Second Hospital 35
Testing effectiveness (Phase 2)Ended earlyNCT01392352
What this trial is testing

HYPAZ: Hypertension Induced by Pazopanib

Who this might be right for
Renal Cell CarcinomaSoft Tissue SarcomaGlioblastoma+8 more
Cambridge University Hospitals NHS Foundation Trust 31
Not applicableStudy completedNCT05858749
What this trial is testing

Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 494
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Early research (Phase 1)Active Not RecruitingNCT04483778
What this trial is testing

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more
Seattle Children's Hospital 68
Not applicableTemporarily pausedNCT05210933
What this trial is testing

Study of Minimally-invasive Ablative Renal Therapies (SMART) Registry

Who this might be right for
Renal Cancer
University of Alberta 750
Not applicableLooking for participantsNCT07575347
What this trial is testing

Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)

Who this might be right for
Periodontal DiseasePeriodontitisCKD+6 more
Stefan Lujinschi 100
Not applicableStudy completedNCT02499458
What this trial is testing

Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer

Who this might be right for
Clear Cell Renal CancerCirculating Tumor CellsCirculating Endothelial Cells+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 44
Early research (Phase 1)Study completedNCT02035358
What this trial is testing

Immunotherapy Study for Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic Clear-cell Renal CancerRecurrent Renal Cell Carcinoma+2 more
NewLink Genetics Corporation 18
Testing effectiveness (Phase 2)Looking for participantsNCT07023432
What this trial is testing

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

Who this might be right for
Active SurveillanceClear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 78
Not applicableEnded earlyNCT04106167
What this trial is testing

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Who this might be right for
Advanced Solid TumorLymphomaGastric Cancer+15 more
Fate Therapeutics 20
Next Page
992